Buy Stocks Easy | About Us
January 26, 2022
Buy Stocks Easy | Online Stocks

RARE


Buy Ultragenyx Pharmaceutical Inc. Stock (symbol: RARE) Easy Online

Company Name: Ultragenyx Pharmaceutical Inc.

Symbol: RARE

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

RARE Current Share Price

Today's RARE ( Ultragenyx Pharmaceutical Inc. ) opening price: $

Yesterday's RARE ( Ultragenyx Pharmaceutical Inc. ) closing price: $

Ultragenyx Pharmaceutical Inc. Stock ( symbol: RARE ) Price Chart since IPO (2014):

12 Months Ultragenyx Pharmaceutical Inc. Stock ( symbol: RARE ) Price Chart

Popular Questions about Ultragenyx Pharmaceutical Inc. Public Stock ( RARE )

A: Ultragenyx Pharmaceutical Inc. stock symbol (also called stock or share ticker) is RARE

A: Ultragenyx Pharmaceutical Inc. IPO (Initial Public Offering) took place on 2014

A: Ultragenyx Pharmaceutical Inc.'s stock (RARE symbol) price at ther IPO (initial Public Offering) was $

Q: Is RARE stock worth buying at the moment?

A: The RARE stock performance since 2019 are rather disappointing. If you had bought 1 share of Ultragenyx Pharmaceutical Inc. stock (symbol: RARE) at the beginning of 2019, at the opening share price of $49.3200, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Ultragenyx Pharmaceutical Inc. Stock Easy Online

Ultragenyx Pharmaceutical Inc. Stock Ticker Price Chart since IPO:





Ultragenyx Pharmaceutical Inc. Stock Price Yesterday



 


Ultragenyx Pharmaceutical Inc. Stock Price – Last Week




 


Ultragenyx Pharmaceutical Inc. Stock Price – Last Month




 


Ultragenyx Pharmaceutical Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/18/1962189/0/en/Ultragenyx-Announces-Sale-of-Future-European-Royalties-on-Crysvita-burosumab-for-320-Million-to-Royalty-Pharma.html
                            

                                
Ultragenyx Announces Sale of Future European Royalties on Crysvita® (burosumab) for $320 Million to Royalty Pharma

                                
                                
NOVATO, Calif. and NEW YORK, Dec.  18, 2019  (GLOBE NEWSWIRE) -- Ul...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/analyst-ratings/analyst-color/19/12/15004313/8-biotech-stocks-morgan-stanley-recommends-for-2020
                            

                                
8 Biotech Stocks Morgan Stanley Recommends For 2020

                                
                                
Biotech investing is risk-fraught, but for investors who make the r...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/26/1952628/0/en/Ultragenyx-to-Present-at-Piper-Jaffray-31st-Annual-Healthcare-Conference.html
                            

                                
Ultragenyx to Present at Piper Jaffray 31st Annual Healthcare Conference

                                
                                
NOVATO, Calif., Nov.  26, 2019  (GLOBE NEWSWIRE) -- Ultragenyx Phar...


                            

                        
                    

                


                            

                    


                        
                            https://www.forbes.com/sites/greatspeculations/2019/11/19/why-ultragenyx-pharmaceutical-stock-has-dropped-40-in-the-last-quarter/
                            

                                
Why Ultragenyx Pharmaceutical Stock Has Dropped 40% In The Last Quarter

                                
                                
Ultragenyx Pharmaceuticals (NASDAQ: RARE), a biopharmaceutical comp...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/606628/ultragenyx-rare-reports-wider-than-expected-loss-in-q3
                            

                                
Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q3

                                
                                
Ultragenyx (RARE) reports wider-than-expected loss and misses sales...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4302939-ultragenyx-pharmaceutical-inc-rare-ceo-emil-kakkis-q3-2019-results-earnings-call-transcript
                            

                                
Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q3 2019 Results - Earnings Call Transcript

                                
                                
Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q3 2019 Re...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/605150/ultragenyx-rare-reports-q3-loss-lags-revenue-estimates
                            

                                
Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates

                                
                                
Ultragenyx (RARE) delivered earnings and revenue surprises of -14.6...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/30/1937860/0/en/Ultragenyx-to-Host-Conference-Call-for-Third-Quarter-2019-Financial-Results-and-Corporate-Update.html
                            

                                
Ultragenyx to Host Conference Call for Third Quarter 2019 Financial Results and Corporate Update

                                
                                
NOVATO, Calif., Oct.  30, 2019  (GLOBE NEWSWIRE) -- Ultragenyx Phar...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/588381/ultragenyx-rare-expected-to-beat-earnings-estimates-should-you-buy
                            

                                
Ultragenyx (RARE) Expected to Beat Earnings Estimates: Should You Buy?

                                
                                
Ultragenyx (RARE) possesses the right combination of the two key in...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.